Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant.

Viruses · 2021 · PMC8703303 · PMID 34960820

Europe PMC DOI

hedged sentence

0.0048

closest p · 0.1× alpha

0.0048

boldest claim

The sentences

highly significantp = 0.0048actually significant

This was a highly significant difference ( p = 0.0048, Fisher’s exact test) in mortality between the Venus control and the combined vaccine groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.